Income before deduction of interest, taxes and amortization: CEL-SCI Corporation (CVM)
CEL-SCI Corporation is developing the unique Multikine system to stimulate immunity prior to surgical intervention. The risk mitigation strategy relies on the early activation of the body's defensive forces, while streamlined air transport ensures the stable delivery of medications. The operating profit history in monetary terms on GURU.Markets reflects liquidity dynamics, with 0.00 becoming the new value of the indicator.
Summary analytical data breakdowns for CEL-SCI (CVM)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- business debt structure and liquidity details:
- earnings and market multiples details:
CVM - Net Profit|Company Profit Forecast CEL-SCI Corporation|CVM - Price to Earnings Ratio|Future Price to Earnings Multiple CEL-SCI Corp.|CVM - PEG Multiple|Enterprise Value to EBITDA Ratio CEL-SCI|CVM - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months CEL-SCI|CVM - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months cel-sci.com|CVM - Earnings per share growth in current year|Net earnings per share change forecast for next year CEL-SCI Corporation
Fundamental company valuation:CVM, CEL-SCI Corporation
This metric measures a business's ability to generate cash flow from core operations before deducting taxes and interest, reflecting the actual volume of fundamental value created. By analyzing the EBITDA_Co trend on the GURU.Markets platform, an investor can assess how effectively the CEL-SCI Corporation (CVM) immune activation ecosystem is monetized with the Multikine drug, which confirms the company's financial stability when scaling cancer treatment protocols.
Competitors of CEL-SCI Corporation (CVM)
Operating profit EBITDA BeiGene Oncology ONC|HALO - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization RVMD (revmed.com)|AAPG: Operating profit EBITDA|Profit before interest, taxes and amortization CG Oncology Inc (CGON)|URGN (UroGen) - Operating profit EBITDA|Operating profit before deduction of amortization Bicara Corp (BCAX)|Operating profit EBITDA PSNL|ERAS - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Delcath Systems DCTH|Y-mAbs Therapeutics Inc - Profit before payment of interest, taxes and amortization|AURA: Operating profit before deduction of amortization|Operating profit before depreciation charges Candel Therapeutics (CADL)|Accuray Incorporated (ARAY) - Profit before payment of interest, taxes and amortization|SLS - Operating income before deduction of amortization|ACTU (Actuate Therapeutics) - Operating profit EBITDA|Operating profit before deduction of amortization Citius Oncology Inc. (CTOR)|Operating profit EBITDA HURA|Operating income before deduction of amortization Protara Tx|Fate Therapeutics, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization WHWK|TScan - Operating profit EBITDA|Champions Oncology (CSBR) - Operating profit before deduction of amortization|xbiotech.com (XBIT) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization OS Therapies, Inc. (OSTX)|Profit before payment of interest, taxes and amortization Radiopharm Theranostics|ARTV: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Adlai Nortye Ltd. (ANL)|VERU: Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Tempest Tx TPST|Xilio Therapeutics Inc (XLO) - Profit before interest, taxes and amortization|RENB - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization MURA (Mural Oncology plc)|KAPA: Operating profit EBITDA|OnKure Therapeutics (OKUR) - Operating profit EBITDA|Operating profit before deduction of amortization GDTC|CRIS (Curis Corp) - Company profit before taxes, interest and amortization|Operating profit EBITDA APLM|Operating income before deduction of amortization tharimmune.com|Profit before payment of interest, taxes and amortization Advanced Biomed ADVB|Genprex Inc. (GNPX) - Profit before interest, taxes and amortization|CLDI - Profit before payment of interest, taxes and amortization|SBFM (sunshinebiopharma.com) - Operating profit before amortization|XBIO: Operating profit EBITDA|Operating profit before deduction of amortization salariuspharma.com|Operating profit before deduction of amortization PPBT|Profit before payment of interest, taxes and amortization AONC|Profit before payment of interest, taxes and amortization BeOne Medicines (BGNE)|Operating profit before deduction of amortization Checkpoint Therapeutics Inc CKPT|Operating profit EBITDA ELEV (Elevation Oncology)|ICAD - Operating profit before deduction of amortization|Ikena - Operating profit EBITDA|NTBL - Operating profit EBITDA|viracta.com (VIRX) - Profit before payment of interest, taxes and amortization|Operating profit before amortization MOR|NAYA (NAYA Biosciences) - Operating profit EBITDA|Operating profit before deduction of amortization ascentage.com (AAPGV)
